Keybanc has initiated coverage on Hims & Hers Health Inc (HIMS) with a Sector Weight rating. This marks the firm's first assessment of the company's investment potential, reflecting their research into the business, industry dynamics, and growth prospects.
Hims & Hers Health operates a telehealth consultation platform, providing access to treatments for various chronic conditions, including sexual health, hair loss, and mental health. The company, headquartered in San Francisco, employs 1,637 full-time staff and went public on September 9, 2019. Currently, HIMS boasts a market cap of $9.3 billion, a P/E ratio of 48.25, and an EPS of 0.79.
Looking ahead, the company is set to report its next earnings on August 2, 2026, with analysts estimating an EPS of $0.27 and revenue of $683.9 million.
Analyst ratings provide insights based on research and financial models, but they represent professional opinions that may not always align with actual outcomes. Investment decisions should take into account a range of factors, including company fundamentals and individual financial goals. As new information emerges, analyst ratings can change, and perspectives may vary among different analysts.